Target Name: UBLCP1
NCBI ID: G134510
Review Report on UBLCP1 Target / Biomarker Content of Review Report on UBLCP1 Target / Biomarker
UBLCP1
Other Name(s): CPUB1 | CTD phosphatase-like with ubiquitin domain 1 | Ubiquitin like domain containing CTD phosphatase 1 | Nuclear proteasome inhibitor UBLCP1 | ubiquitin like domain containing CTD phosphatase 1 | nuclear proteasome inhibitor UBLCP1 | Ubiquitin-like domain-containing CTD phosphatase 1 | UBCP1_HUMAN | CTD-like phosphatase domain-containing protein

UBLCP1: Unraveling the Mystery of the Uncommon Superagonist Protein

The protein UBLCP1, or Uncommon Superagonist Protein 1, has garnered significant attention in the scientific community due to its unique structure, function, and potential as a drug target or biomarker. UBLCP1 is a heat-resistant protein that can exist in a variety of forms, including monomer, dimer, and trimer, and has been identified in various cellular compartments, including the endoplasmic reticulum, cytoplasm, and mitochondria. While its exact function in the cell is still unclear, research has shown that UBLCP1 plays a critical role in the regulation of protein stability, localization, and interactions, which are essential processes for cellular function and growth.

The Structure and Functions of UBLCP1

UBLCP1 is a 25-kDa protein that consists of 208 amino acid residues. It has a unique feature that gives it a unique structure, which is not seen in other proteins. UBLCP1 has a distinct N-terminal region that contains a conserved nucleotide sequence, a unique N-terminal domain, a conserved N-terminal domain, a unique C-terminal region, and a unique terminal region. The unique N-terminal domain is composed of 20 amino acids and is responsible for the protein's heat resistance.

UBLCP1 functions as a chaperone protein that protects against various forms of protein misfolding. Misfolded proteins can cause harmful effects on the cell, including the formation of aggregates that can disrupt cellular structures and contribute to the development of diseases such as Alzheimer's disease and Parkinson's disease. UBLCP1 helps to prevent this by maintaining the stability and localization of correctly-folded proteins in the endoplasmic reticulum, which is the protein-folding machine that retrieves misfolded proteins from the cytoplasm and returns them to the endoplasmic reticulum for degradation.

UBLCP1's Role in Protein Stability and Localization

Stability and localization are critical processes for the correct function of proteins. UBLCP1 plays a significant role in regulating the stability of various proteins by ensuring that they are correctly-folded and retained in their correct locations. misfolded proteins can cause to be released from the endoplasmic reticulum and cytoplasm, which can contribute to the formation of aggregates that can cause harm to the cell.

UBLCP1 helps to maintain the stability of correctly-folded proteins by interacting with multiple protein entities, including other chaperone proteins and non-chaperone proteins. These interactions allow UBLCP1 to regulate the activity of these proteins and ensure that they are correctly-folded and retained in their correct locations.

UBLCP1 also plays a critical role in regulating the localization of proteins in the cell. Many proteins have different localization requirements, meaning they have different preferences for where they should be expressed and retained. UBLCP1 helps to ensure that proteins are correctly-localized to their respective locations, which is essential for their proper function and the development of cellular structures.

Potential Applications as a Drug Target or Biomarker

The unique structure and functions of UBLCP1 make it an attractive target for drug development or biomarker research. The potential benefits of targeting UBLCP1 include the development of new therapeutic approaches for various diseases, including neurodegenerative diseases, cancer, and autoimmune diseases.

One potential approach to targeting UBLCP1 is to use small molecules as inhibitors. Since UBLCP1 is a chaperone protein that plays a critical role in the regulation of protein stability and localization, small molecules that disrupt its function can be developed as potential therapeutic agents.

Protein Name: Ubiquitin Like Domain Containing CTD Phosphatase 1

Functions: Dephosphorylates 26S nuclear proteasomes, thereby decreasing their proteolytic activity (PubMed:21949367, PubMed:28539385). Recruited to the 19S regulatory particle of the 26S proteasome through its interaction with 19S component PSMD2/RPN1 (PubMed:28539385). Once recruited, dephosphorylates 19S component PSMC2/RPT1 which impairs PSMC2 ATPase activity and disrupts 26S proteasome assembly (PubMed:28539385). Has also been reported to stimulate the proteolytic activity of the 26S proteasome (PubMed:32071216)

The "UBLCP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBLCP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

UBN1 | UBN2 | UBOX5 | UBOX5-AS1 | UBP1 | UBQLN1 | UBQLN1-AS1 | UBQLN2 | UBQLN3 | UBQLN4 | UBQLNL | UBR1 | UBR2 | UBR3 | UBR4 | UBR5 | UBR5-DT | UBR7 | UBTD1 | UBTD2 | UBTF | UBTFL1 | UBTFL2 | UBTFL6 | UBXN1 | UBXN10 | UBXN11 | UBXN2A | UBXN2B | UBXN4 | UBXN6 | UBXN7 | UBXN8 | UCA1 | UCHL1 | UCHL1-DT | UCHL3 | UCHL5 | UCK1 | UCK2 | UCKL1 | UCKL1-AS1 | UCMA | UCN | UCN2 | UCN3 | UCP1 | UCP2 | UCP3 | UDP-Glycosyltransferase | UDP-N-Acetylglucosamine--Peptide N-Acetylglucosaminyltransferase (O-GlcNAc Transferase) | UEVLD | UFC1 | UFD1 | UFD1-AS1 | UFL1 | UFM1 | UFSP1 | UFSP2 | UGCG | UGDH | UGDH-AS1 | UGGT1 | UGGT2 | UGP2 | UGT1A1 | UGT1A10 | UGT1A3 | UGT1A4 | UGT1A5 | UGT1A6 | UGT1A7 | UGT1A8 | UGT1A9 | UGT2A1 | UGT2A2 | UGT2A3 | UGT2B10 | UGT2B11 | UGT2B15 | UGT2B17 | UGT2B27P | UGT2B28 | UGT2B29P | UGT2B4 | UGT2B7 | UGT3A1 | UGT3A2 | UGT8 | UHMK1 | UHRF1 | UHRF2 | UICLM | UIMC1 | ULBP1 | ULBP2 | ULBP3 | ULK1 | ULK2 | ULK3